International Biotechnology (LON:IBT) Stock Price Passes Below 200-Day Moving Average – What’s Next?

International Biotechnology (LON:IBT)’s stock price passed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 680.90 ($8.57) and traded as low as GBX 674 ($8.48). International Biotechnology shares last traded at GBX 680 ($8.56), with a volume of 39,054 shares.

International Biotechnology Stock Down 0.6 %

The stock has a market capitalization of £251.33 million, a price-to-earnings ratio of 1,416.67 and a beta of 0.21. The firm has a 50-day moving average of GBX 694.15 and a 200 day moving average of GBX 680.90. The company has a debt-to-equity ratio of 9.66, a current ratio of 0.46 and a quick ratio of 0.32.

International Biotechnology Increases Dividend

The company also recently announced a dividend, which will be paid on Friday, January 24th. Investors of record on Thursday, December 19th will be paid a GBX 15.56 ($0.20) dividend. The ex-dividend date is Thursday, December 19th. This is a boost from International Biotechnology’s previous dividend of $14.50. This represents a dividend yield of 2.21%. International Biotechnology’s dividend payout ratio (DPR) is currently 6,041.67%.

Insider Buying and Selling

In other International Biotechnology news, insider Katherine Cornish-Bowden purchased 1,500 shares of International Biotechnology stock in a transaction that occurred on Tuesday, December 17th. The stock was acquired at an average price of GBX 713 ($8.97) per share, for a total transaction of £10,695 ($13,457.91). 4.18% of the stock is owned by corporate insiders.

About International Biotechnology

International Biotechnology Trust plc specializes in investments in development stage and late stage companies. The majority of the fund's assets are generally invested in smaller and mid-capitalization quoted companies, with a minority in larger capitalization quoted companies. It makes long only investments.